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Reply
We agree with the first 2 assertions made by Drs. Lampert and
Myerburg regarding our paper (1). First, cost projections in our
paper reflect on the entire screening process, not just electrocar-
diography (ECG) screening. Second, “prices” rather than “costs”
were presented and we alluded to that distinction in our paper (1).
Our model presents not only the “number needed to screen,” but
also the partition of secondary tests (mainly driven by an abnormal
ECG) that are necessary to save 1 life. One may enter any price
deemed “appropriate” and calculate a new cost per life saved.
Obviously, all these cost projections assume that the data reported
in Italy by Corrado et al. (2) are not only correct, but are also
applicable to other societies.
We used cost per life saved rather than “costs per life-year
saved” (1). However, assuming that all athletes with hypertrophic
cardiomyopathy will have a normal lifespan if only identified
through screening but would die otherwise is unsubstantiated. It is
also incorrect to use Wheeler et al.’s cost-effectiveness analysis (3)
s a standard for comparison. Wheeler et al. (3) also based their
alculations on the Italian study by Corrado et al. (2) and credited
he number of lives saved to ECG screening but dramatically
educed cost calculations by ignoring that ECG screening was
epeated 20 times during the study period.
Lampert and Myerburg argue that ECG screening programs
erformed less frequently “have also saved lives,” citing a study by
anaka et al. (4). However, Tanaka et al. (4) never demonstrated
hat athletes’ lives are actually saved by ECG screening. Instead,
hey reported the incidence of sudden death among 37,000 high
chool students undergoing ECG screening at 3-year intervals: 3
oys died suddenly during follow-up, representing a sudden-death
ate of 1.32 in 100,000/year. Importantly, 2 of the 3 calamities had
normal ECG and were actually missed by screening. The third
atality was disqualified from competitive sports because of hyper-
rophic cardiomyopathy, only to die suddenly, years later, while
ogging on his own. The latter case in point is a poignant reminder
hat disqualification of afflicted athletes from organized sports will
ot always translate into normal longevity. True, 8 additional
tudents were identified as high-risk individuals (6 of them were
ot athletes). It is appropriate to conclude from the Tanaka et al.
tudy that systematic ECG screening of high-school students mayidentify high-risk characteristics in 1:4,200 adolescents (9 in
37,807). However, counting all identified high-risk individuals as
“lives saved” would be grossly erroneous.
We never advocated abandoning screening but we do object to
the concept of mandatory ECG screening of athletes because the
benefit of ECG-screening for the prevention of sudden death in
athletes remains unproven. Proponents of ECG screening must
accept that the level of evidence supporting such a strategy has not
reached the stage that justifies making this test mandatory. We
simply do not know enough about the natural history of many
conditions identified by screening to provide an accurate esti-
mation of risk. We should not compel athletes to undergo
unsolicited tests when all too often we do not know what to do
with the results (5).
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